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CC BY-NC-ND license (http://creativeAbstract Objective: Lipid droplet (LD) deposition in adipose tissue is a critical factor leading
to metabolic dysfunction. Various herbal medicines in traditional Chinese medicine (TCM) are
used to treat hyperlipidemia, type 2 diabetes, obesity, and other diseases. The objective of
this study was to identify potential anti-adipogenic agents from TCM herbal compounds.
Methods: One hundred and twenty compounds were evaluated in terms of their effect on
adipocyte differentiation through image-based high content screening. Anti-adipogenic effects
of identified hits were further confirmed at various concentrations. In addition, drug-induced
liver injury assay was performed with HepG2 cells to test the hepatotoxicity of hit compounds.
Results: Berbamine (BBM), a chemical isolated from barberry, and a derivative of BBM, berba-
mine dihydrochloride (BBMD), reduced LDs formation by more than 50%. Dose-dependent ef-
fects were observed and the IC50 values of the two hits, BBM and BBMD, were determined as
1.88 mM and 0.95 mM, respectively. Moreover, BBM induced mild HepG2 cell injury, while its di-
hydrochloridedBBMD did not exhibit hepatotoxicity within 40 mM.
Conclusion: This study demonstrates that BBMD may be a potential therapeutic candidate for
disorders associated with elevated LDs accumulation.
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an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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Lipid droplets (LDs) are dynamic intracellular organelles
that play an important role in cellular lipid storage and
trafficking.1 LDs mainly contain triglycerides, the metabolic
precursor diacylglycerol,2 and perilipin.3 Overloaded
intracellular LDs are associated with metabolic diseases
such as obesity, insulin resistance, non-alcoholic fatty liver
disease (NAFLD), and type 2 diabetes.4 Recent research by
Tirinato et al5 showed that high levels of LDs were present
in colorectal cancer stem cells, and may thus be a cellular
target for innovative anticancer therapies. LDs are mainly
stored in adipose tissue. Also, 3T3-L1 preadipocyte derived
from Swiss mouse embryo tissue is a typical fat-storage cell
line that differentiates into mature adipocytes when stim-
ulated by hormone cocktail, consisted by insulin, dexa-
methasone, and 3-Isobutyl-1-methylxanthine (IBMX).6 In
research, 3T3-L1 adipocytes were used as a target for the
discovery of anti-adipogenic drugs.7
Currently, there are three main approaches for quanti-
fying LDs. The first (conventional) method, which is labor
intensive and time consuming, is to use oil red O staining
and signal acquisition by ultraviolet spectroscopy. The
second method is a label-free method, with bright-field
microscopy8 and spectroscopy imaging5 as examples. The
third method applies lipophilic fluorescent dyes specific for
neutral LDs,9 which makes high-content detection of LDs in
3T3-L1 adipocytes feasible. These assays have facilitated
discovery of novel anti-adipogenic ingredients.
Metabolic disorders generally require long-term intake
of lipid-regulating drugs. The liver is the primary organ for
both fat and drug metabolism, and is thus subjected to
potential hazardous agents. Therefore, during drug devel-
opment, attention must be paid to drug safety. For
example, individuals with NAFLD are exposed to a high risk
of drug-induced liver injury (DILI) during long-term con-
sumption of anti-hyperlipidemia drugs.10 Using drug-
induced liver toxicity assays, with high sensitivity and
specificity developed by high throughput format11e13 is
paramount for predicting the safety of the identified hits at
early stage of drug discovery.
In China, many traditional herbs are prescribed for
regulating lipid metabolism, such as milk thistle (Silybum
marianum (L.) Gaertn.),14 salvia root (Salvia miltiorrhiza
Bunge), astragalus root (Astragalus membranaceus (Fisch.)
Bunge),15 cassia seed (Senna obtusifolia (L.) H.S.Irwin &
Barneby),16 and coptis rhizome (Coptis chinensis
Franch.).17 However, understanding of the molecular bio-
activities of these plants remains incomplete. The aim of
the present study was to screen and identify novel anti-
adipogenic agents from Chinese herbs and to predict their
hepatotoxicity using a high-content imaging assay.
Materials and methods
Herbal compounds and reagents
A total of 120 traditional Chinese medicine (TCM) herbal
compounds with diverse chemical structures were pur-
chased from the Beijing Institute for Drug Control (Beijing,
China) and Dalian Institute of Chemical Physics (Dalian,China). The purity of all the compounds was >98%. The test
compounds were derived from Chinese herbs that are
commonly prescribed and are thus readily available.
Compounds were dissolved in dimethyl sulphoxide
(DMSO) and immediately stored at 20C as a stock solution
for testing. A ToxInsight Drug Induced Liver Injury (DILI)
Cartridge was purchased from Thermo Scientific (Waltham,
MA, USA). Dulbecco’s modified Eagle’s medium (DMEM) and
fetal bovine serum (FBS) were obtained from Gibco (Grand
Island, NY, USA). Dexamethasone, 3-isobutylxanthine
(IBMX), lovastatin, Nile Red, Hoechst 33342, and all other
chemicals were purchased from SigmaeAldrich (Saint Louis,
MO, USA), if not otherwise stated.
Induction of adipogenic differentiation
3T3-L1 pre-adipocytes (American Type Culture Collection,
Manassas, VA, USA) were cultured in 10-cm dishes in DMEM
supplemented with 10% FBS, 100 unit/mL penicillin, and
100 mg/mL streptomycin. Cultures were maintained in a
humidified atmosphere of 5% CO2 in air at 37
C. 3T3-L1
adipocytes differentiation was performed as reported pre-
viously.18 Plating of cells was defined as Day 1. Initiation of
differentiation was conducted on Day 4, and promotion of
differentiation was done on Day 6 using insulin medium
(1 mg/mL). The differentiation medium comprised 0.5 mM
IBMX, 1 mg/mL insulin, 0.25 mM dexamethasone, and 2 mM
rosiglitazone. Adipocytes were incubated further in DMEM
complete culture medium for 2 days. For determination of
the Z0 factor, 30 differentiated and 30 undifferentiated
wells were performed in parallel.
Chemical treatment
TCM test compounds were added to confluent 3T3-L1 pre-
adipocytes from Day 3, and were continuously present for 6
days. During primary screening, 120 test compounds were
prepared at a concentration of 4 mM in 100% DMSO, and
then diluted into 100 mM using DMEM complete culture
medium. For doseeresponse titration, tested compounds
were three-fold serially diluted in DMSO from 12 mM stock
solutions and were further diluted into complete culture
medium. Three replicates were performed in parallel for
each dose.
Staining and imaging of 3T3-L1 adipocytes
By the end of cell differentiation (Day 10), culture media
were removed and cells were rinsed gently with phosphate-
buffered saline (PBS). First, 100 mL of 4% paraformaldehyde
solution was added to each well and the plates maintained
at 25C for 20 min, followed by rinsed with PBS. Next, 100 mL
of 5 mg/mL freshly prepared Nile Red solution was applied to
each well and incubated at 25C for 10 min. Then Nile Red
solution was removed and the plate was rinsed with PBS.
Finally, 10 mg/mL Hoechst 33342 was added to cells and
kept at 25C for 15 min, followed by rinsed with PBS.
Signals of lipid droplets and nuclei staining in 3T3-L1
adipocytes were captured using the imaging platform Cel-
lomics ArrayScan VTI HCS Reader (Thermo Scientific) with
a 10  objective lens; eight fields per well were scanned.
Identification of berbamine dihydrochloride 93Images were analyzed using the Cellomics Cell Health
Profiling BioApplication v4 protocol (Thermo Scientific).
DILI assay
Evaluation of hepatotoxicity was conducted according to
procedures described previously.18 Briefly, hepatocellular
carcinoma (HepG2) cells were seeded in 96-well micro-
plates (8000 cells/well) in complete DMEM. The cells were
incubated overnight at 37C. TCM test compounds were
added to cells and incubated for 24 h. Aspirin was used as a
non-toxic drug control with a maximum concentration of
554 mM (100  the maximum concentration in plasma
(Cmax)). Gemfibrozil (GEM) was used as a positive control at
a maximum concentration of 850 mM (100  Cmax). Berb-
amine (BBM) and berbamine dihydrochloride (BBMD) were
each serially diluted twofold from 40 mM.
Staining and imaging of HepG2 cells
A ToxInsight DILI Assay Cartridge was used to simulta-
neously monitor cell nuclei, glutathione (GSH), reactiveFigure 1 High-content imaging assay. (A) Nile Red-labeled lip
adipocytes and mature adipocytes. 0.25% DMSO-treated 3T3-L1 a
bar Z 50 mm. (B) Scatter plot distribution of the percentage of lip
tiated pre-adipocytes (solid triangle). (C) Doseeresponse curve ofoxygen species (ROS), and the mitochondrial membrane
potential (MMP). Imaging of live cells was achieved by
addition of 100 mL of DMEM culture medium containing
four fluorescent dyes to each well. Plates were main-
tained at 37C for 45 min. To minimize photo-bleaching,
cells were gently rinsed once with Hank’s balanced salt
solution. Images were captured immediately on the Cel-
lomics ArrayScan VTI HCS Reader, and analyzed using the
Cellomics Compartmental Analysis v4 protocol (Thermo
Scientific).
Statistical analyses
Data was representative of at least three repeated exper-
iments. Statistical analyses were done with GraphPad Prism
v5.0 (GraphPad, La Jolla, CA, USA). The Student’s t-test
was used for comparison of individual groups; P < 0.05 was
considered significant. The Z0 factor was calculated using
the following formula19:
Z0 Z 1  3  {(SD(differentiated) þ SD(undifferentiated))/
(Mean(differentiated)  Mean(undifferentiated))}id droplets and Hoechst 33342-stained nuclei in 3T3-L1 pre-
dipocytes were defined as negative controls (n Z 6). Scale
id droplets in mature adipocytes (solid circle) and undifferen-
lovastatin for accumulation of lipid droplets.
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Figure 2 Chemical structures of (A) berbamine and (B) berbamine dihydrochloride.
Figure 3 Primary screening of inhibitors of the formation of lipid droplets at 10 mM. (A) Representative images of 3T3-L1 adipocytes
labeled with Nile Red and Hoechst 33342 incubated with or without a test compound. Scale barZ 50 mm. (B) Primary screening at
10 mM. 3T3-L1 pre-adipocytes were incubated in parallel in the absence of differentiation and used as blank controls. Mature adi-
pocytes were used as negative controls and defined as 100%. (C) Viability of 3T3-L1 adipocytes treated with test compounds; the
percentage was normalized to that for the negative control. Data represent mean value of three independent experiments.
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control and inhibitory percentage was determined accord-
ing to the following formula:
Inhibition
(%) Z 100  {Intensity(sample)  Intensity(undifferentiated)}/
{Intensity(differentiated)  Intensity(undifferentiated)}Results
Anti-adipogenic assay development
To discover novel anti-adipogenic agents from 120 TCM
herbal compounds, a high-content imaging assay of adipo-
cyte differentiation was developed. 3T3-L1 adipocytes
were differentiated as described in the Materials and
Methods section. Adipocytes with stained LDs were
defined as differentiated cells, while adipocytes absent of
LDs were defined as quiescent cells (Fig. 1A). The Z0 factor
represents the robustness of the assay, and was determined
to be 0.63 (n Z 30), and the signal/noise ratio was 11
(Fig. 1B), suggesting that the assay was feasible for high-
content screening. Lovastatin was used as a positive con-
trol and a dose-dependent response was observed. The
half-maximal inhibitory concentration (IC50) was 1.4 mM
(Fig. 1C), which was in general agreement with IC50 values
reported previously.20Figure 4 Inhibitory effects of berbamine (BBM) and berbamine d
adipocytes. (A) Doseeresponse curve of the effect of BBM on LD fo
formation. (C) Number of BBM- and BBMD-treated 3T3-L1 adipoc
represented as the mean (SEM), n Z 6, ***P < 0.001.Screening for anti-adipogenic compounds
The high-content imaging assay was applied to 120 TCM
compounds. Fifty-percent inhibition was considered the
cutoff criterion. BBM (Fig. 2A) and one of its derivatives,
BBMD (Fig. 2B), were identified. The number and size of LDs
decreased significantly (P < 0.001) in BBM- and BBMD-
treated adipocytes (Fig. 3A). Inhibition by BBM and BBMD
attained a maximum of 90%, whereas a small cluster of
compounds exhibited negative inhibition values, as illus-
trated by accentuation of LD accumulation in adipocytes
(Fig. 3B). Viability of adipocytes was assessed by staining
using Hoechst 33342. Viability of adipocytes treated by BBM
or BBMD declined slightly, but the decline did not reach 50%
(Fig. 3C).
Confirmation of the anti-adipogenic effect of BBM
and BBMD
To verify the anti-adipogenic effects of BBM and BBMD, we
created doseeresponse curves from a maximum final con-
centration of 30 mM. BBM and BBMD reduced LD deposition
potently in 3T3-L1 adipocytes in a dose-dependent manner.
IC50 values of BBM and BBMD were 1.88 mM (Fig. 4A) and
0.95 mM (Fig. 4B), respectively. BBM and BBMD did not in-
fluence cell viability within 10 mM, but obvious cell losses
were caused by BBM and BBMD at 30 mM (P < 0.001)
(Fig. 4C). Therefore, treatment of BBM or BBMD at 10 mMihydrochloride (BBMD) on formation of lipid droplets in 3T3-L1
rmation. (B) Doseeresponse curve of the effect of BBMD on LD
ytes. All datasets were normalized to negative controls and
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Figure 6 Determination of hepatotoxicity for test compounds using the Euclidean distance and angle. (A) Test compounds with
points outside the thresholds were defined as “toxic”. (B) Ranking of compounds that induced hepatotoxicity was based on the
maximum Euclidean distance and angle. The longer the Euclidean distance and the larger the angle, the stronger the
hepatotoxicity.
Identification of berbamine dihydrochloride 97could achieve up to 80% inhibitory effect, while used at
30 mM could induce cytotoxicity.
Hepatotoxicity evaluation of BBM and BBMD
To assess the potential hepatotoxic effects of BBM and
BBMD, we undertook in vitro DILI assays using HepG2 cells.
Fluorescence images of nuclei, GSH, ROS, and MMP in
HepG2 cells were captured on four channels (Fig. 5A).
Sensitivity and specificity of the assays were 100% as
determined by the ToxInsight DILI assay. Toxicity thresholds
were calculated based on responses to aspirin. GEM (posi-
tive control) induced obvious cell loss, DNA condensation,
GSH depletion, ROS formation, and MMP alteration. BBMD
did not induce remarkable phenotypic alteration of HepG2
cells, whereas BBM decreased cell number slightly, induced
DNA condensation, promoted GSH and ROS formation, and
altered the MMP response (Fig. 5BeF). These data sug-
gested that BBMD may be less hepatotoxic than BBM.
Euclidean distance and angle were applied to determine
the extent of hepatotoxicity based on five representative
biomarkers. A single dose point of BBM exceeded the
threshold constructed by the angle and Euclidean distance,
so it was denoted as “toxic”. Dose plots of BBMD were
within thresholds so BBMD was denoted as “non-hepato-
toxic” (Fig. 6A). Furthermore, we ranked the responses to
liver toxicity based on a triangular area constructed by the
maximum Euclidean distance and angle. GEM showed the
strongest hepatotoxicity and was ranked number one. BBM
was ranked number two and its response was much weaker
than that of GEM. BBMD was quite similar to the negative
control (aspirin) (Fig. 6B). These data further confirmedFigure 5 Evaluation of the hepatotoxicity of berbamine (BBM) an
of HepG2 cells. Nuclei, reduced glutathione (GSH), intracellular re
potential (MMP) were stained with a ToxInsight DILI Assay Cartridge
40 mM berbamine (BBM), or 40 mM berbamine dihydrochloride (BBMD
the vehicle control. Dashed lines denote toxicity thresholds determi
aspirin: T Z mean  3  SD. Scale bar Z 50 mm. For cell number (
DNA content (D), GSH (D), and MMP (F), responses outside the bid
sponses above the dashed lines were denoted as toxic. Data are ththat BBMD was free of toxicity within the concentrations
tested.
Discussion
BBM is a natural bisbenzylisoquinoline alkaloid isolated
mainly from the root of the TCM barberry (Berberis vulgaris
L.). BBM content in barberry ranges from 1.59% to 3.67%
depending on geographic distribution in China.21,22 BBMD is
a dihydrochloride derivate of BBM. This is the first study to
report the inhibitory effects of BBM and BBMD on adipocyte
differentiation and LD deposition.
Studies have shown that BBM possesses various biologic
properties. Xu et al23 found that BBM exhibited anti-
leukemia activity by inhibiting expression of the bcr/abl
fusion gene. Other studies have shown that BBM can induce
inhibition of proliferation of liver tumors by targeting Ca2þ/
calmodulin-dependent protein kinase II (CAMKII).24,25 In-
vestigations on the effects of BBM on cancer cells have also
been carried out. Research by Wang et al26 suggested that
BBM inhibited proliferation of HepG2 cells (IC50 z 35 mM)
and induced apoptosis of HepG2 cells. Wei et al27 demon-
strated that BBM inhibited chronic myelogenous leukemia
cell growth by up to 20 mM. However, cytotoxicity may be
weakened if BBD is transformed into BBMD. Fang et al28
suggested that O-4-ethoxyl-butyl-berbamine (a derivative
of BBM) reversed liver toxicity induced by doxorubicin and
pegylated doxorubicin. The present study suggests that BBM
and BBMD suppressed LD accumulation at relatively low
doses (<10 mM) without obvious cell injury but that in-
creases in concentration could increase the risk of adverse
reactions.d berbamine dihydrochloride (BBMD). (A) Fluorescence images
active oxygen species (ROS), and the mitochondrial membrane
. Cells were incubated with 554 mM aspirin, 425 mM gemfibrozil,
). Test compound-induced responses were normalized to that of
ned based on the mean response and standard deviation (SD) of
B), responses below the threshold were defined as “toxic”; for
irectional dashed lines were denoted as toxic; for ROS (E), re-
e mean of three independent experiments.
98 S. Wang et al.Our findings suggest that BBMD could be applied against
infection by the hepatitis-C virus (HCV) and Mycobacterium
tuberculosis. LDs are important in the assembly and repli-
cation of the HCV.29,30 Thus, LD depletion may reduce the
stability of the HCV core and facilitate HCV treatment. In
the latency period of infection by M. tuberculosis, LDs
serve as energy sources for M. tuberculosis persistence.31
Therefore, BBMD may provide a therapeutic approach for
HCV infection and tuberculosis through its ability to inhibit
LD formation. Nonetheless, the underlying molecular
mechanism elucidating how BBM and BBMD regulated
adipocyte differentiation demands further investigation.
Still, drug induced liver injury assay in vitro we employed
was dependent on the Cmax value of test drug. Meanwhile,
the Cmax values of BBM and BBMD were currently not
accurately determined, which may somewhat influence the
accuracy of prediction.
Conclusions
In summary, the current study developed a high content
image-based assay incorporating lipid droplet analysis and
drug induced liver injury, which meets the demand for high
throughput anti-adipogenic agent discovery. We identified
BBM and BBMD from a library of TCM compounds as in-
hibitors of LD formation in 3T3-L1 adipocytes. By comparing
their efficacies and potential hepatotoxic responses, BBMD
was found to exert superior bioactivity and weaker adverse
effects than BBM. Our discovery of a novel regulator of LD
metabolism could provide an alternative avenue for treat-
ment of lipid-associated diseases.
Author contributions
Shifeng Wang conducted the main experiments and wrote
the manuscript. Qiao Zhang and Qinghua Wu undertook
imaging analyses. Yanling Zhang and Yuxin Zhang provided
writing assistance. Yanjiang Qiao and Shiyou Li designed the
study.
Conflicts of interest
The authors report no conflict of interest.
Acknowledgment
This work was supported by a grant from the National
Natural Science Foundation of China (grant number
81430094).
References
1. Guo Y, Cordes KR, Farese RV, Walther TC. Lipid droplets at a
glance. J Cell Sci. 2009;122:749e752.
2. Kuerschner L, Moessinger C, Thiele C. Imaging of lipid biosyn-
thesis: how a neutral lipid enters lipid droplets. Traffic. 2008;
9:338e352.
3. Barneda D, Frontini A, Cinti S, Christian M. Dynamic changes in
lipid droplet-associated proteins in the “browning” of white
adipose tissues. Biochim Biophys Acta. 2013;1831:924e933.4. Kiss E, Kra¨nzlin B, Wagenblab K, et al. Lipid droplet accumu-
lation is associated with an increase in hyperglycemia-induced
renal damage: prevention by liver X receptors. Am J Pathol.
2013;182:727e741.
5. Tirinato L, Liberale C, Di Franco S, et al. Lipid droplets: a new
player in colorectal cancer stem cells unveiled by spectro-
scopic imaging. Stem Cells. 2015;33:35e44.
6. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte dif-
ferentiation. Physiol Rev. 1998;78:783e809.
7. Nawrocki AR, Scherer PE. Keynote review: the adipocyte as
a drug discovery target. Drug Discov Today. 2005;10:
1219e1230.
8. Dragunow M, Cameron R, Narayan P, O’Carroll S. Image-based
high-throughput quantification of cellular fat accumulation. J
Biomol Screen. 2007;12:999e1005.
9. Spandl J, White DJ, Peychl J, Thiele C. Live cell multicolor
imaging of lipid droplets with a new dye, LD540. Traffic. 2009;
10:1579e1584.
10. Michaut A, Moreau C, Robin MA, Fromenty B. Acetaminophen-
induced liver injury in obesity and nonalcoholic fatty liver
disease. Liver Int. 2014;34:171e179.
11. Xia M, Huang R, Witt KL, et al. Compound cytotoxicity profiling
using quantitative high-throughput screening. Environ Health
Perspect. 2008;116:284e291.
12. Jetten MJ, Kleinjans JC, Claessen SM, Chesne C, Van Delft JH.
Baseline and genotoxic compound induced gene expression
profiles in HepG2 and HepaRG compared to primary human
hepatocytes. Toxicol In Vitro. 2013;27:2031e2040.
13. O’Brien PJ, Irwin W, Diaz D, et al. High concordance of drug-
induced human hepatotoxicity with in vitro cytotoxicity
measured in a novel cell-based model using high content
screening. Arch Toxicol. 2006;80:580e604.
14. Suh HJ, Cho SY, Kim EY, Choi HS. Blockade of lipid accumula-
tion by silibinin in adipocytes and zebrafish. Chem Biol
Interact. 2015;227:53e62.
15. Zhao J, Zhu H, Wang S, et al. Naoxintong protects against
atherosclerosis through lipid-lowering and inhibiting matura-
tion of dendritic cells in LDL receptor knockout mice fed a
high-fat diet. Curr Pharm Des. 2013;19:5891e5896.
16. Fu F, Tian F, Zhou H, et al. Semen cassiae attenuates
myocardial ischemia and reperfusion injury in high-fat diet
streptozotocin-induced type 2 diabetic rats. Am J Chin Med.
2014;42:95e108.
17. Zhang Z, Zhang H, Li B, et al. Berberine activates thermo-
genesis in white and brown adipose tissue. Nat Commun. 2014;
5:5493.
18. Wang S, Zhai C, Liu Q, et al. Cycloastragenol, a triterpene
aglycone derived from Radix astragali, suppresses the accu-
mulation of cytoplasmic lipid droplet in 3T3-L1 adipocytes.
Biochem Biophys Res Commun. 2014;450:306e311.
19. Zhang J, Chung TD, Oldenburg KR. A simple statistical param-
eter for use in evaluation and validation of high throughput
screening assays. J Biomol Screen. 1999;4:67e73.
20. Nishio E, Tomiyama K, Nakata H, Watanabe Y. 3-Hydroxy-3-
methylglutaryl coenzyme A reductase inhibitor impairs cell
differentiation in cultured adipogenic cells (3T3-L1). Eur J
Pharmacol. 1996;301:203e206.
21. Lu GH, Chen JM, Xiao PG. Determination of alkaloids in the
roots of Berberis genus plants by HPLC with varied wavelength.
Acta Pharm Sin. 1995;30:280e285 [Chinese].
22. Di DL, Wang Q, Ma ZG, Jiang SX. Distribution of four alkaloids in
plants of Berberis. J Chin Med Mater. 2004;27:83e86
[Chinese].
23. Xu R, Dong Q, Yu Y, et al. Berbamine: a novel inhibitor of
bcr/abl fusion gene with potent anti-leukemia activity. Leuk
Res. 2006;30:17e23.
24. Meng Z, Li T, Ma X, et al. Berbamine inhibits the growth of
liver cancer cells and cancer-initiating cells by targeting
Identification of berbamine dihydrochloride 99Ca2þ/calmodulin-dependent protein kinase II. Mol Cancer
Ther. 2013;12:2067e2077.
25. Gu Y, Chen T, Meng Z, et al. CaMKII gamma, a critical regulator
of CML stem/progenitor cells, is a target of the natural product
berbamine. Blood. 2012;120:4829e4839.
26. Wang GY, Lu¨ QH, Dong Q, Xu RZ, Dong QH. Berbamine induces
Fas-mediated apoptosis in human hepatocellular carcinoma
HepG2 cells and inhibits its tumor growth in nude mice. J Asian
Nat Prod Res. 2009;11:219e228.
27. Wei YL, Xu L, Liang Y, Xu XH, Zhao XY. Berbamine exhibits
potent antitumor effects on imatinib-resistant CML cells
in vitro and in vivo. Acta Pharmacol Sin. 2009;30:451e457.28. Fang BJ, Yu ML, Yang SG, Liao LM, Liu JW, Zhao RC. Effect of O-
4-ethoxyl-butyl-berbamine in combination with pegylated
liposomal doxorubicin on advanced hepatoma in mice. World J
Gastroenterol. 2004;10:950e953.
29. Miyanari Y, Atsuzawa K, Usuda N, et al. The lipid droplet is an
important organelle for hepatitis C virus production. Nat Cell
Biol. 2007;9:1089e1097.
30. Filipe A, McLauchlan J. Hepatitis C virus and lipid droplets:
finding a niche. Trends Mol Med. 2015;21:34e42.
31. Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F, et al. Is ad-
ipose tissue a place for Mycobacterium tuberculosis persis-
tence? PLoS One. 2006;1:e43.
